DRKS00004291尚未招募不适用
Feasibility studies of the Pretest 2 phase of the German National Cohort- A nationwide study for health and frequent diseases in Germany
Helmholtz- Zentrum für Infektionsforschung0 个研究点目标入组 200 人开始时间: 2012年8月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 69 Years（—）
- 性别
- All
入选标准
- •Residents from the Hanover city and region who volunteer to participate in the study will be included.
排除标准
- •Pregnant women and women who gave birth in the past 30 days will be excluded form the vaginal self-sampling study. Patients with arrythmias will be excluded from the Vasoscreen 3000 study.
研究者
相似试验
已完成
2 期
ECF Gastric StudyCancer - StomachGastric CancerACTRN12605000701628AGITG sponsored trial conducted through NHMRC CTC60
进行中（未招募）
1 期
An investigation of the feasibility of using a topical formulation of lidocaine (SHACT) for hysteroscopy in women.Investigating the feasibility of using a topical formulation.MedDRA version: 16.0Level: PTClassification code 10064882Term: Procedural painSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2013-001775-20-SEPharmanest AB10
尚未招募
不适用
A study investigating the feasibility of stereotactic radiotherapy for the palliation of Head and Neck CancerHead and Neck CancerCancer - Head and neckACTRN12621001548820South Western Sydney Local Health District40
进行中（未招募）
1 期
A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diffuse large B-cell lymphoma.EUCTR2017-002605-35-BEHOVON Foundation109
进行中（未招募）
1 期
A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diffuse large B-cell lymphoma.EUCTR2017-002605-35-NLHOVON Foundation109